3
9
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3359 |
Aprotinin
抑酶肽,抑肽酶,Bovine Pancreatic Trypsin Inhibitor,Traskolan,Antilysin |
Others; Serine Protease; Influenza Virus; Proteasome | Microbiology/Virology; Others; Proteases/Proteasome; Ubiquitination |
Aprotinin (Traskolan) 是分离自牛肺的一种广谱丝氨酸蛋白酶抑制剂,可抑制多种不同酯酶和蛋白酶的活性。 | |||
TP1379 |
KKI-5 TFA(97145-43-2 free base)
KKI-5 (TFA) |
||
KKI-5 (TFA) is a specific tissue kallikrein inhibitor.Kki-5 (TFA) can reduce breast cancer cell infiltration. | |||
T77999 |
KKI-5 TFA
|
||
KKI-5 (TFA)为特异性组织激肽释放酶抑制剂,能有效减少乳腺癌细胞的浸润性。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00891 |
Kallikrein 2/KLK2 Protein, Human, Recombinant (His)
hGK-1,Kallikrein-2,Tissue Kallikrein |
Human | HEK293 Cells |
Kallikrein-2 (KLK2) is a secreted serine protease that belongs to the peptidase S1 family of Kallikrein subfamily. KLK2 contains 1 peptidase S1 domain. It is highly expressed in the human prostate gland. KLK2 can cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin, but Preferential cleavages of Arg-|-Xaa bonds in small molecule substrates. It also highly selective action to release kallidin (lysyl-bradykinin) from kininogen involves hydrolysis of Met-|-Xaa or Leu-|-Xaa. KLK2 ... | |||
TMPJ-00475 |
Kallikrein 1/KLK1 Protein, Human, Recombinant (aa 19-262, His)
Tissue Kallikrein,Kidney/Pancreas/Salivary... |
Human | HEK293 Cells |
Kallikrein-1 (KLK1) is a member of human tissue Kallikrein family. Human KLK1 precursor contains a singal peptide (residues 1 to 18), a short pro peptide (residues 19 to 24) and a mature chain (residues 25 to 262). The function of KLK1 is to cleave Kininogen in order to release the vasoactive Kinin peptide (Lysyl-Bradykinin or Bradykinin). The Kinin peptide controls blood pressure reduction, vasodilation, smooth muscle relaxation and contraction, pain induction and inflammation. KLK1 also plays ... | |||
TMPK-00766 |
KLKB1 Protein, Human, Recombinant (His)
PKK,Kininogenin,KLK3,KLKB1,Fletcher factor,Plasma kallik... |
Human | HEK293 Cells |
Plasma kallikrein, also known as Fletcher factor or kallikrein B1 (KLKB1), is a serine endopeptidase, like its homologs tissue kallikrein and kallikrein-related peptidases (KLKs). Its physiological role is to catalyze the release of kinins and other vasoactive peptides. KLKB1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 70.3 kDa and the accession number is P03952. | |||
TMPK-00857 |
KLKB1 Protein, Mouse, Recombinant (His)
Kininogenin,KLK3,Fletcher factor,Plasma kallikrein,... |
Mouse | HEK293 Cells |
Plasma kallikrein, also known as Fletcher factor or kallikrein B1 (KLKB1), is a serine endopeptidase, like its homologs tissue kallikrein and kallikrein-related peptidases (KLKs). Its physiological role is to catalyze the release of kinins and other vasoactive peptides. KLKB1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 70.3 kDa and the accession number is P26262. | |||
TMPK-00525 |
KLKB1 Protein, Cynomolgus, Recombinant (His)
KLK3,Plasma kallikrein,KLKB1,PKK,Kininogenin,Fletch... |
Cynomolgus | HEK293 Cells |
Plasma kallikrein, also known as Fletcher factor or kallikrein B1 (KLKB1), is a serine endopeptidase, like its homologs tissue kallikrein and kallikrein-related peptidases (KLKs). Its physiological role is to catalyze the release of kinins and other vasoactive peptides. KLKB1 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 70.19 kDa and the accession number is A0A2K5VTJ9. | |||
TMPJ-00544 |
Kallikrein 7/KLK7 Protein, Human, Recombinant (aa 23-252, His)
PRSS6,Serine Protease 6,hK7,Stratum Corneum Chymotryptic Enz... |
Human | HEK293 Cells |
Human Kallikrein 7 is a member of the tissue kallikrein family of extracellular serine proteases that is made up of 15 members. It is predominantly expressed in the skin. A major physiological function of Kallikrein 7 is to regulate the desquamation process (the shedding of corneocytes from the outer layer of the epidermis) through proteolysis of the intercellular adhesive structures between corneocytes. Dysregulation of Kallikrein 7 has been linked to several inflammatory skin diseases includin... | |||
TMPY-00867 |
Kallikrein 13/KLK13 Protein, Human, Recombinant (His)
KLKL4,kallikrein-related peptidase 13,KLK-L4 |
Human | HEK293 Cells |
Tissue kallikrein 13 (hK13), also known as KLK-L4 (kallikrein-like gene 4), is a member of the human tissue kallikrein family of serine proteases having diverse physiological functions in many tissues. The KLK13 gene resides on chromosome 19q13.3-4 along with other 14 members in a gene cluster and shares a high degree of homology. KLK13 is a trypsin-like, secreted serine protease expressed specifically in the testicular tissue including prostate, salivary gland, breast, and testis. Growing evide... | |||
TMPJ-00931 |
Serpin A4 Protein, Human, Recombinant (His)
Kallistatin,Peptidase Inhibitor 4,KST,Kallikrein In... |
Human | HEK293 Cells |
Serpin Peptidase Inhibitor, Clade A (α-1 Antiproteinase, Antitrypsin), Member 4 (Serpin A4) is a member of the Serpin family. Serpin A4 exists as a monomer and some homodimers. Serpin A4 is expressed by the liver and secreted in plasma. Serpin A4 is a regulator of vascular homeostasis capable of controlling a wide spectrum of biological actions in the cardiovascular and renal systems. It can inhibit intracellular reactive oxygen species formation in cultured cardiac and renal cells. In addition,... | |||
TMPH-02832 |
Serpin A5 Protein, Mouse, Recombinant (His)
|
Mouse | Baculovirus Insect Cells |
Heparin-dependent serine protease inhibitor acting in body fluids and secretions. Inactivates serine proteases by binding irreversibly to their serine activation site. Involved in the regulation of intravascular and extravascular proteolytic activities. Plays hemostatic roles in the blood plasma. Acts as a procoagulant and proinflammatory factor by inhibiting the anticoagulant activated protein C factor as well as the generation of activated protein C factor by the thrombin/thrombomodulin comple... |